Welcome to our dedicated page for Logitech Intl S A SEC filings (Ticker: LOGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From MX Master mice to Blue Yeti microphones, Logitech鈥檚 product lines span the desks of gamers, streamers, and remote workers worldwide. That breadth shows up in every Logitech annual report 10-K simplified, where segment revenues for gaming, video collaboration, and pointing devices move the stock. If you have ever wondered, 鈥淗ow can I see Logitech insider trading Form 4 transactions as they happen?鈥� or searched for a Logitech quarterly earnings report 10-Q filing, this page delivers the answers immediately.
Stock Titan鈥檚 AI-powered platform turns dense disclosures into clear takeaways. Our engine provides Logitech SEC filings explained simply, highlighting supply-chain risks, currency impacts, and sustainability metrics within seconds. AG真人官方-time alerts surface Logitech Form 4 insider transactions real-time, while concise dashboards offer Logitech earnings report filing analysis without scrolling through 200 pages.
Here鈥檚 what you can explore today:
- 10-K and 10-Q summaries that reveal how each business group鈥攇aming, video collaboration, creative鈥攄rives gross margin
- Instant notifications on Logitech executive stock transactions Form 4 and option exercises
- 8-K briefs for product launches and leadership changes鈥�Logitech 8-K material events explained
- Proxy insights on director pay and Logitech proxy statement executive compensation
Whether you鈥檙e monitoring channel sell-through ahead of the holidays or understanding Logitech SEC documents with AI for a quick valuation model, our coverage keeps you ahead of the next filing. Stop downloading PDFs鈥攇ain the clarity you need the moment EDGAR publishes.
Atomico Advisors IV, Ltd. and its affiliated funds have filed a Schedule 13G disclosing a passive ownership position in Hinge Health, Inc. (HNGE) following the company鈥檚 23 May 2025 IPO.
- Aggregate beneficial ownership: 6,713,063 Class B shares, convertible 1-for-1 into Class A.
- Economic stake equals 8.3 % of the 80,597,784 total shares outstanding post-IPO.
- All voting and dispositive power is reported as shared; no sole power.
- Class B shares carry 15 votes per share, giving Atomico considerably greater voting influence than its economic interest implies; this higher voting weight is not reflected in the 8.3 % figure because percentages are shown on an as-converted basis.
- The filing is made under Rule 13d-1(c)/(d), indicating a passive investment intent with no activist agenda disclosed.
The disclosure confirms that a prominent venture investor has retained a meaningful stake through the IPO. While it does not change financial outlook, the dual-class structure heightens governance concentration, a consideration for shareholders assessing control dynamics.
Middlesex Water Company (NASDAQ: MSEX) filed a Rule 424(b)(5) prospectus supplement dated 29 Jul 2025 to continue its direct share purchase, sale and dividend reinvestment program (the 鈥淚nvestment Plan鈥�). The filing registers the remaining 712,353 unsold shares of common stock previously registered on Form S-3 (File No. 333-266482) and shifts them to the new shelf registration (File No. 333-287177) dated 12 May 2025. Shares may be issued directly by the company or purchased in the open market; any proceeds provide a flexible, low-cost source of equity capital.
The Plan allows first-time investors to start with $500鈥�$10,000 (or $25 monthly ACH) and existing holders to reinvest dividends or make optional cash purchases up to $25,000 per quarter. Plan shares may occasionally be offered at a discount at the company鈥檚 discretion, though no specific discount is currently set. Key risks highlighted include share-price volatility between order and execution, potential tax liabilities on reinvested dividends, and the possibility that dividends may be reduced or suspended. The company鈥檚 last reported market price was $51.52 on 28 Jul 2025; no proceeds estimate, use-of-funds detail or earnings data are provided in this supplement.
Coca-Cola Consolidated (COKE) Q2-25 10-Q highlights
- Net sales rose 3.3% YoY to $1.86 bn; first-half sales up 1.4% to $3.44 bn.
- Gross profit +3.6% to $742 m; gross margin steady at 40.0%.
- Operating income +5.0% to $272 m; operating margin 14.7% (+30 bp).
- Net income increased 8.5% to $187 m; diluted EPS $2.15 (+16%). First-half EPS $3.34 (-8%).
- Interest expense swung to a $6 m cost from a $2 m benefit YoY, reflecting higher average debt after 2024 bond issuance.
- Mark-to-market expense on acquisition-related contingent consideration fell to $12 m vs $28 m, easing below-the-line pressure.
- 1H-25 operating cash flow slipped 7% to $406 m; capex $157 m kept free cash flow modest.
- Cash & equivalents climbed to $1.22 bn; total debt unchanged at $1.79 bn, leaving net debt of $0.57 bn.
- Equity strengthened to $1.63 bn as retained earnings rose and buybacks ($35 m) reduced share count under the $1 bn program.
- Dividend lifted to $0.25 per share post 10-for-1 split effective 27-May-25.
Takeaway: Stable volume-driven revenue growth and cost discipline are expanding margins, but higher financing costs and softer first-half earnings temper the story. Robust liquidity and active capital returns support shareholder value.
Houlihan Lokey, Inc. filed a Form 144 indicating a proposed sale of 200 common shares through Morgan Stanley Smith Barney on 14 July 2025. The aggregate market value of the shares to be sold is $37,918, versus 53,789,857 shares outstanding, representing a negligible 0.0004% of total shares.
The filer previously executed two Rule 10b5-1 sales for the same account鈥�200 shares on 13 June 2025 for $34,874 and 200 shares on 13 May 2025 for $35,692. The securities being sold were acquired as restricted stock on 26 May 2021. No material adverse information was acknowledged by the seller, as required under Rule 144 representations.
This notice reflects routine insider share disposition activity. The transaction size is immaterial relative to market capitalization and does not appear to signal a strategic change or financial stress for HLI.